Work

Re: Counterfeit Phosphodiesterase Type 5 Inhibitors Pose Significant Safety Risks

Year: 2011

Type: letter

Source: The Journal of Urology

DOI: 10.1016/s0022-5347(11)60427-8

Author: Steven A. Kaplan

Language: English

Topic: Pharmaceutical Quality and Counterfeiting

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1988408326

Cites:

Cited by:

Related to: 10